High impact research from the CambridgeIP-Boliven team

• Telehealth technology comes of age?

  

  CambridgeIP patent landscaping research finds that up to 89% of medical device patents involve wireless technology. The research, covering more than 26,000 telehealth related patents, has identified emerging patenting hotspots and changing market dynamics in telehealth technologies. Read CambridgeIP’s press release to find out more. You can also download the report. Here on Boliven.com, you can conduct your own analysis of the underlying patent datasets by visiting our blood glucose monitors Boliven Landscape.

• Patent Citations, Geographic Spread and the role of China as a patent destination

  In CambridgeIP's report on AIM-listed patent-intensive companies they identified a subset of 68 AIM-listed companies that represent the bulk of patenting activity: out of more than 1,600 total companies. This is just one of the many interesting findings that can be found in the discussion of the report here.

• Patents: When to sell & when to buy

  The opportunity exists in these pressing economic times for the canny investor to secure patents at a fraction of past prices. Moreover, there may be an increased opportunity to selectively acquire high value IP assets, rather than needing to acquire the IP bundled with other assets of less value to the investor.

• Advanced Corporate Uses of Patent-based Intelligence

  CambridgeIP_s Ilian Iliev and Quentin Tannock led a workshop for the Licensing Executives Society for Britain and Ireland (LES-BI). The workshop_s focus was on Advanced Corporate Uses of Patent-based Intelligence_ in the context of an economic slowdown. The 30+ participants included IP managers from major corporations, University Technology Transfer Offices and SMEs; as well as IP service providers.

• Marketing your technology in the credit crunch

  Quentin Tannock and Miranda Weston-Smith, presented a tutorial on _marketing your technology in the credit crunch_ for representatives drawn from a select set of Technology Transfer Officers at four leading UK Universities.

• Responsible Licensing for the Developing World

  _As a community of practitioners we can and should do more to provide innovative technology licensing solutions to our clients _ in both the developed and developing world_ As the market for low-carbon energy will increase exponentially, licensing solutions that may have been untenable in the past can become attractive_ This was the opening statement by CambridgeIP_s Ilian Iliev presenting to a group of licensing executives, IP managers and IP lawyers at London_s science museum on the topic of _Responsible Licensing for the Developing World_.

• Technology Transfer Offices (TTOs) working with Corporate partners

  Quentin Tannock participated on a panel in the Tech Transfer Summit at EuroBio 2009 that considered the topic of TTOs working with Corporate partners. The audience was a mixture of major Pharma corporations, biotech companies and TTOs.

• Unripe Fruit: How can we protect and market early stage technology?

  This blog address the topic of 'Unripe Fruit: How can we protect and market early stage technology?'. This topic developed from the Tech Transfer Summit of EuroBio 2009 panal Quentin Tannock attended and prensented summary results on process and timescales followed by TTOs from 21 leading UK Universities.

• A New Era for the Pharmaceutical Propellants

  CambridgeIP_s Arthur Lallement presented at the Drug Delivery for Lungs conference at Edinburgh on December 9, 2009. Over four hundred senior scientists from the inhaler and respiratory disease industry attended the conference and shared some of the latest research in the inhaler space.

• Patents and Potency: The Stem Cell Patent Landscape

  Julian Hitchcock of Field Fisher Waterhouse LLP contributed this guest blog entry:
  The grant of a patent for induced pluripotent stem cells (iPSCs) in the United Kingdom in January and the notice issued by the US Patent and Trademark Office in February allowing claims under a US patent application entitled _Methods for Reprogramming Somatic Cells_ signal a significant new feature of the stem cell patent landscape. But don_t imagine that stem cell patents are about to become straightforward.

• The Economics of Climate Change: IP Ownership, Taking the Lead

  This blog article provides an overview of the January 2010 Chevening Lecture by CambridgeIP_s Quentin Tannock. The lecture covers ethical and policy issues, the facts on the ground in terms of IP ownership, the impact of international conventions and national policies on IP activity and the range of options for technology transfer in Low Carbon Technology spaces.

• Harvard Business Review: 'Can Technology Really Save Us from Climate Change?'

  Harvard Business Review cites IP analysis in the Cleantech space done by CambridgeIP and Chatham House as a potential market tool to help direct the future clean-tech landscape more effectively. In addition, the article postulates on the potential influence of IP analysis to methodologically underpin a 'Moore's Law' for clean technology

• Harvard Business Review: 'Can Technology Really Save Us from Climate Change?'

  Harvard Business Review cites IP analysis in the Cleantech space done by CambridgeIP and Chatham House as a potential market tool to help direct the future clean-tech landscape more effectively. In addition, the article postulates on the potential influence of IP analysis to methodologically underpin a 'Moore's Law' for clean technology

• Business Strategy: Putting IP at the Centre

  CambridgeIP contributed to the Innovation UK report on the topic of IP strategy. An effective IP strategy can become a centerpiece for a company's internationalisation strategy: providing it with leverage and protection across diverse markets, facilitating the generation of additional revenue through licensing activity, as well as currency for negotiating with large corporate partners.

• Protecting and Growing Corporate Assets: A Strategic Case

  CambridgeIP's Ilian Iliev was a guest contributor to BusinessXL's special October edition focused on 'Why IP matters'. In his article Ilian argues that despite the downturn, a comprehensive and strategically integrated IP strategy remains key to long-term value creation.